Strong Price Performance and Momentum
On 12 Mar 2026, Venus Remedies Ltd (Stock ID: 568580) recorded an intraday high of Rs.912, representing a day gain of 5.67%. This marks the highest price level the stock has achieved in the past year, surpassing its previous 52-week high. The stock has demonstrated remarkable resilience, outperforming its Pharmaceuticals & Biotechnology sector by 5.61% on the same day.
The stock’s recent price trajectory has been notably robust, with a consecutive gain streak spanning seven trading sessions. Over this period, Venus Remedies Ltd has delivered a substantial return of 39.01%, reflecting sustained buying interest and positive market sentiment towards the company.
Technical indicators further reinforce the bullish trend. The stock is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment of moving averages is typically indicative of a strong upward momentum and investor confidence in the stock’s near-term prospects.
Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!
- - New Top 1% entry
- - Market attention building
- - Early positioning opportunity
Comparative Performance and Market Context
Venus Remedies Ltd’s one-year performance stands out sharply against the broader market benchmark. The stock has appreciated by an impressive 212.38% over the past 12 months, vastly outperforming the Sensex, which has recorded a modest gain of 3.01% during the same period. This stark contrast highlights the stock’s exceptional growth trajectory within the Pharmaceuticals & Biotechnology sector.
In comparison, the stock’s 52-week low was Rs.277.85, underscoring the magnitude of the recent rally. The current price level of Rs.912 represents a near threefold increase from that low point, reflecting strong investor conviction and favourable company developments.
Meanwhile, the broader market environment has been less supportive. The Sensex opened 494.06 points lower and is trading at 76,255.99, down 0.79% on the day. The index is also experiencing a three-week consecutive decline, losing 7.92% in that span. Additionally, several indices including the S&P Bse Dollex 30, NIFTY IT, and S&P Bse Teck hit new 52-week lows today, indicating sector-specific pressures and market volatility.
Technical and Momentum Indicators
Technical analysis of Venus Remedies Ltd reveals a mixed but predominantly positive outlook. Daily moving averages signal a bullish trend, with the stock price comfortably above all key averages. Monthly and weekly Bollinger Bands also indicate bullish momentum, suggesting sustained price strength.
However, some weekly indicators such as MACD and KST show mild bearish signals, while monthly MACD and KST remain bullish. The Dow Theory assessment is mildly bullish on a weekly basis but mildly bearish monthly, reflecting some caution in longer-term momentum. On Balance Volume (OBV) readings are mildly bearish on both weekly and monthly charts, indicating some divergence between price gains and volume flows.
Overall, the technical landscape suggests that while short-term momentum is strong, there are nuanced signals that warrant monitoring for any shifts in trend dynamics.
Mojo Score and Rating Update
Venus Remedies Ltd currently holds a Mojo Score of 67.0, categorised as a Hold grade. This represents a downgrade from its previous Buy rating, which was revised on 11 Mar 2026. The Market Cap Grade stands at 4, reflecting the company’s mid-tier market capitalisation within its sector.
The rating adjustment reflects a balanced view of the company’s fundamentals and market performance, acknowledging the recent price surge while considering broader valuation and momentum factors.
Venus Remedies Ltd or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Industry Positioning
Operating within the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd’s recent price performance distinguishes it from peers amid a mixed market backdrop. While several indices related to technology and IT sectors have declined to new lows, Venus Remedies has demonstrated resilience and growth, supported by sector-specific dynamics and company-level factors.
The stock’s ability to maintain gains above all major moving averages and its strong relative performance against the sector benchmark underscore its current leadership position within its industry group.
Summary of Key Metrics
To summarise, Venus Remedies Ltd’s key market data as of 12 Mar 2026 includes:
- New 52-week and all-time high price: Rs.912
- Day’s price change: +5.67%
- Consecutive gain days: 7
- 7-day return: +39.01%
- One-year return: +212.38%
- Sensex one-year return: +3.01%
- Mojo Score: 67.0 (Hold grade)
- Market Cap Grade: 4
This data highlights the stock’s exceptional price appreciation and technical strength relative to the broader market and sector peers.
Conclusion
Venus Remedies Ltd’s achievement of a new 52-week high at Rs.912 marks a significant milestone reflecting strong momentum and sustained gains over recent weeks. Despite a challenging market environment characterised by declines in major indices and sector pressures, the stock has outperformed substantially, supported by positive technical indicators and robust price action. The recent downgrade to a Hold rating reflects a measured assessment of the company’s fundamentals alongside its market performance.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
